Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research materials to sidestep regulatory scrutiny.

Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg has shown promising results in early-phase trials; the efficacy of the ...

Lilly's Kisunla gets FDA approval for a new dosing schedule that significantly lowers ARIA-E risk while maintaining amyloid ...

The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...

By Vijay Kumar Malesu An important international trial shows that combining cagrilintide and semaglutide helps adults with obesity achieve more dramatic weight loss and better metabolic health ...

Wegovy is a prescription injection used for weight loss and reduction of cardiovascular risks. Learn about its dose escalation, form, strengths, and more.

A cagrilintide-only group in the obesity study presented at the ADA meeting lost an average of 11.5 per cent of their body weight. Novo hopes that could create a new market.

Learn about the dosages for Botox in treating migraine, incontinence, muscle spasticity, and more. You can also find information on how the drug’s given.

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses of its blockbuster weight loss medicine Zepbound.

A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile. | A second ...

REDEFINE 1 and 2 are 68-week phase 3 studies evaluating the safety and effectiveness of CagriSema, a once-weekly combination of weight-loss medications semaglutide and cagrilintide.